1 asset in Congenital Heart Disease
Therapeutic assets addressing Congenital Heart Disease, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Tirzepatide Congenital Heart Disease | University Medical Centre Ljubljana | P4 | BB (65) |